Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Psychiatr Res. 2016 Nov 17;86:9–17. doi: 10.1016/j.jpsychires.2016.11.007

Figure 1.

Figure 1

Greater DA signaling capacity, as reflected by MGP scores, was related to lower negative symptom severity as measured by the Brief Negative Symptom scale (BNSS) across diagnostic groups. HC, healthy control; SIB, sibling of individual with schizophrenia; SCZ, individual diagnosed with schizophrenia or schizoaffective disorder; MGP, multilocus genetic profile.